XRP experienced a remarkable rebound in the fourth quarter of 2024, soaring 280% after years of regulatory setbacks.
Ripple’s latest market report attributes this resurgence to a shift in U.S. policy, with President Donald Trump’s executive order emphasizing clearer regulations and fair access to banking for crypto businesses. The policy change has reinvigorated investor confidence, leading to heightened institutional and retail demand for XRP.
Before facing legal pressure from the SEC, XRP was among the top cryptocurrencies by market value. Ripple claims that regulatory actions suppressed its growth, but with restrictions easing, the asset has regained momentum.
Trading volumes skyrocketed, with Binance handling 36% of XRP’s spot trading activity, followed by Upbit Korea at 20% and Coinbase at 9%. Following Trump’s election, daily trading volume jumped from $500 million to an average of $5 billion, hitting a record $25 billion on December 2.
Institutional interest in XRP continues to rise, with firms like WisdomTree and CoinShares seeking approval for an XRP ETF, alongside applications from Bitwise, Canary Capital, and 21Shares. Ripple sees the final months of 2024 as a turning point, with regulatory clarity and increased adoption setting the stage for long-term growth in the digital asset space.
ARK Invest has quietly deepened its exposure to Solana by adding a staked SOL investment to two of its tech-focused ETFs, signaling growing confidence in the blockchain’s long-term potential.
The U.S. Securities and Exchange Commission (SEC) is warming up to the idea of expanding the crypto ETF landscape beyond Bitcoin, with 72 crypto-related ETF proposals now awaiting review.
Coinbase has officially rolled out CFTC-regulated futures contracts tied to XRP, marking a significant step forward for institutional adoption of the Ripple-associated token.
A fresh wave of speculation has hit the crypto market following a hefty stablecoin issuance by Tether, which quietly minted $1 billion worth of USDT on the Tron network earlier today.